• Hikma, GSK stop talks over potential buyout deal of Egypt, Tunisia assets expresspharma
    March 12, 2021
    Hikma Pharmaceuticals and GlaxoSmithKline have ended talks over a potential buyout deal for the latter’s pharma, consumer commercialisation and manufacturing business in Egypt and its drugs business in Tunisia, the companies said.
  • Hikma intends to acquire assets in Egypt, Tunisia expresspharma
    January 27, 2021
    Hikma Pharmaceuticals said it was planning to buy GSK’s stake in some assets including the drugmaker’s pharma, consumer commercialisation and manufacturing business in Egypt and its drugs business in Tunisia.
PharmaSources Customer Service